A detailed history of National Bank Of Canada transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, National Bank Of Canada holds 737 shares of ATAI stock, worth $1,179. This represents 0.0% of its overall portfolio holdings.

Number of Shares
737
Previous 737 -0.0%
Holding current value
$1,179
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.16 - $1.64 $1,456 - $2,059
-1,256 Reduced 63.02%
737 $0
Q4 2023

Feb 06, 2024

SELL
$1.04 - $1.55 $208 - $310
-200 Reduced 9.12%
1,993 $2,000
Q4 2021

Jan 24, 2022

BUY
$6.82 - $17.8 $14,956 - $39,035
2,193 New
2,193 $17,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $265M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.